DARA BioSciences, Inc.: 10-Q filed 2012-05-14
What DARA BioSciences, Inc. reported in its quarterly report filed 2012-05-14 (fiscal Q1 2012): 33 published measures, 87 facts as tagged in accession 0001354488-12-002418.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2012-05-14
- Fiscal period
- fiscal Q1 2012
- Accession
- 0001354488-12-002418 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All DARA BioSciences, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 5,596,347 | USD | |
| At 2011-12-31 | 1,852,342 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 1,758,922 | USD | |
| At 2011-12-31 | 893,194 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 4,116,167 | USD | |
| At 2011-12-31 | 1,174,440 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 1,378,373 | USD | |
| At 2011-12-31 | 1,179,157 | USD | |
| At 2011-03-31 | 4,593,836 | USD | |
| At 2010-12-31 | 5,478,414 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -1,983,876 | USD | 91 |
| 2002-06-22 to 2012-03-31 | -41,481,077 | USD | 3571 |
| 2011-01-01 to 2011-03-31 | -1,248,649 | USD | 90 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -1,403,679 | USD | 91 |
| 2002-06-22 to 2012-03-31 | -43,023,649 | USD | 3571 |
| 2011-01-01 to 2011-03-31 | -1,524,552 | USD | 90 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 6,220 | USD | 91 |
| 2002-06-22 to 2012-03-31 | 206,132 | USD | 3571 |
| 2011-01-01 to 2011-03-31 | 0 | USD | 90 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 1,628,403 | USD | 91 |
| 2002-06-22 to 2012-03-31 | 40,653,507 | USD | 3571 |
| 2011-01-01 to 2011-03-31 | 639,974 | USD | 90 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -25,508 | USD | 91 |
| 2002-06-22 to 2012-03-31 | 3,748,515 | USD | 3571 |
| 2011-01-01 to 2011-03-31 | 0 | USD | 90 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | -41,700,424 | USD | |
| At 2011-12-31 | -39,716,548 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 0 | USD | 91 |
| 2002-06-22 to 2012-03-31 | -194,445 | USD | 3571 |
| 2011-01-01 to 2011-03-31 | 0 | USD | 90 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 44,057 | USD | |
| At 2011-12-31 | 42,455 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 77,151 | USD | 91 |
| 2002-06-22 to 2012-03-31 | 6,896,422 | USD | 3571 |
| 2011-01-01 to 2011-03-31 | 199,979 | USD | 90 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -2,047,316 | USD | 91 |
| 2002-06-22 to 2012-03-31 | -54,007,936 | USD | 3571 |
| 2011-01-01 to 2011-03-31 | -1,319,043 | USD | 90 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 1,817,667 | USD | |
| At 2011-12-31 | 1,462,866 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 10 | USD | 91 |
| 2002-06-22 to 2012-03-31 | -839,583 | USD | 3571 |
| 2011-01-01 to 2011-03-31 | 103 | USD | 90 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 1,738,932 | USD | |
| At 2011-12-31 | 867,995 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 1,176,494 | USD | |
| At 2011-12-31 | 640,817 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 2,047,316 | USD | 91 |
| 2002-06-22 to 2012-03-31 | 54,007,936 | USD | 3571 |
| 2011-01-01 to 2011-03-31 | 1,319,043 | USD | 90 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 315,836 | USD | 91 |
| 2002-06-22 to 2012-03-31 | 25,550,337 | USD | 3571 |
| 2011-01-01 to 2011-03-31 | 396,392 | USD | 90 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 7,698,973 | shares | |
| At 2011-12-31 | 5,600,804 | shares |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 3,837,425 | USD | |
| At 2011-12-31 | 959,148 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 3,237,693 | USD | |
| At 2011-12-31 | 0 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 532,684 | USD | |
| At 2011-12-31 | 140,673 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 439,294 | USD | |
| At 2011-12-31 | 283,709 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -2,047,326 | USD | 91 |
| 2002-06-22 to 2012-03-31 | -43,396,213 | USD | 3571 |
| 2011-01-01 to 2011-03-31 | -1,319,146 | USD | 90 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -2,047,326 | USD | 91 |
| 2002-06-22 to 2012-03-31 | -43,201,768 | USD | 3571 |
| 2011-01-01 to 2011-03-31 | -1,319,146 | USD | 90 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -2,047,326 | USD | 91 |
| 2002-06-22 to 2012-03-31 | -43,201,768 | USD | 3571 |
| 2011-01-01 to 2011-03-31 | -1,319,146 | USD | 90 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 1,656,214 | USD | 91 |
| 2002-06-22 to 2012-03-31 | 28,382,333 | USD | 3571 |
| 2011-01-01 to 2011-03-31 | 922,651 | USD | 90 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 169,228 | USD | 91 |
| 2002-06-22 to 2012-03-31 | 869,750 | USD | 3571 |
| 2011-01-01 to 2011-03-31 | 35,828 | USD | 90 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 0 | USD | 91 |
| 2002-06-22 to 2012-03-31 | 605,462 | USD | 3571 |
| 2011-01-01 to 2011-03-31 | 0 | USD | 90 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -10 | USD | 91 |
| 2002-06-22 to 2012-03-31 | 12,986,145 | USD | 3571 |
| 2011-01-01 to 2011-03-31 | -103 | USD | 90 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 477,707 | USD | 91 |
| 2002-06-22 to 2012-03-31 | 788,524 | USD | 3571 |
| 2011-01-01 to 2011-03-31 | -150,350 | USD | 90 |
Inspect the source
- Entity
- DARA BioSciences, Inc. / CIK 0000919745
- Captured
- SEC response SHA-256
e9ff53e9e757e1304559609921f37ffaa36f777a1b02cc70cf323365e27bd844
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000919745.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))